Market Place
Sourcing Support
Baxter Expands Pharmaceuticals Portfolio with New Injectable Products in the U.S.
12 Apr 2024 //
PRESS RELEASE
Enforcement Report - Week of February 28, 2024
28 Feb 2024 //
FDA
Enforcement Report - Week of April 19, 2023
19 Apr 2023 //
FDA
Enforcement Report - Week of March 8, 2023
08 Mar 2023 //
FDA
Zydus gets USFDA nod to market generic blood pressure lowering drug
21 Jul 2022 //
ECONOMIOC TIMES
Zydus Pharma Generic Norepinephrine Bitartrate Receives Approval in the U.S.
19 Jul 2022 //
FDA
Enforcement Report - Week of March 30, 2022
30 Mar 2022 //
FDA
Enforcement Report - Week of March 02, 2022
02 Mar 2022 //
FDA
FDA Approves Baxter`s Ready-to-use Norepinephrine in Premix Formulation
23 Sep 2021 //
BUSINESSWIRE
Enforcement Report - Week of August 25, 2021
25 Aug 2021 //
FDA
Breckenridge Pharmaceutical Launches Norepinephrine Bitartrate Injection USP
20 Aug 2021 //
PRNEWSWIRE
Gland Pharma Ltd`s Generic Norepinephrine Bitartrate Receives Approval In US
12 May 2021 //
FDA
Enforcement Report - Week of January 1, 2020
01 Jan 2020 //
FDA
Amneal Pharms` Generic Norepinephrine Bitartrate Receives Approval in US
17 Dec 2018 //
FDA
Sandoz`s Generic Norepinephrine Bitartrate Receives Approval in US
24 Oct 2018 //
FDA
Mylan Labs` Generic Norepinephrine BitartrateReceives Approval in US
09 Oct 2018 //
FDA
Enforcement Report - Week of July 25, 2018
25 Jul 2018 //
FDA
Enforcement Report - Week of July 11, 2018
11 Jul 2018 //
FDA
Enforcement Report - Week of November 1, 2017
01 Nov 2017 //
FDA
Enforcement Report - Week of August 16, 2017
16 Aug 2017 //
FDA
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.